V4CURE
Develops peptide-based therapies for patients with severe cardio-renal diseases and rare kidney disorders
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-09
About V4CURE
V4Cure develops synthetic peptide therapies for severe cardio-renal diseases and rare disorders. Its lead candidate, V4C-232, is in preclinical development for refractory ascites and polycystic kidney disease.
The company also describes a biodiversity-driven peptide discovery and engineering platform. It is a spin-off of CEA, received the national i-Lab grant, and is a member of the Paris Biotech Santé incubator. Founded in 2023, it is based in Saint-Cloud, France.
Product: Peptide-based drug candidates and a discovery platform focused on cardio-renal diseases and rare kidney disorders.
Jobs at V4CURE
More biotech & pharma companies
Valerio Therapeutics
Develops precision-targeted antibody therapies for complex and underserved diseasesNew on EvolcValneva
Develops, manufactures and commercializes preventive vaccines for infectious diseases for healthcare professionals and travelersNew on EvolcSalary transparentVaxinano
Vaccine and antigen delivery platform for veterinary and human infectious diseases, including zoonosesNew on EvolcVect-Horus
Develops targeting technology to transport therapeutic and imaging agents across the blood–brain barrier for pharma and biotech partnersNew on EvolcVenipharm
Develops and commercializes generic, biosimilar and niche medicines for pharmaceutical partners and healthcare marketsNew on EvolcVeto-Pharma
Veterinary medicines and contract manufacturing for animal-health businesses and beekeeping professionalsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- hCaptchaHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.